Search Result "CDK clinical trials"
CDK Inhibitors: From the Bench to Clinical Trials
Journal: Current Drug Targets
Volume: 11 Issue: 3 Year: 2010 Page: 279-290
Author(s): Flavio Rizzolio, Tiziano Tuccinardi, Isabella Caligiuri, Chiara Lucchetti, Antonio Giordano
The Prospects of CDK Targeting and Clinical Application of CDK Inhibitors in Cancer
Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 9 Year: 2018
Author(s): Aditi Gangopadhyay,Aparna Gangopadhyay
Doi: 10.2174/9781681087016118090008
Small Molecule CDK Inhibitors for the Therapeutic Management of Cancer
Journal: Current Topics in Medicinal Chemistry
Volume: 20 Issue: 17 Year: 2020 Page: 1535-1563
Author(s): Bharat Goel,Nancy Tripathi,Nivedita Bhardwaj,Shreyans K. Jain
Anticancer Therapeutic Strategies Based on CDK Inhibitors
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 3 Year: 2013 Page: 5327-5332
Author(s): Luca Esposito, Paola Indovina, Flora Magnotti, Daniele Conti, Antonio Giordano
Peptides or Small Molecules? Different Approaches to Develop More Effective CDK Inhibitors
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 2854-2866
Author(s): D. Cirillo, F. Pentimalli, A. Giordano
Advances on Cyclin-dependent Kinases (CDKs) as Novel Targets for Antiviral Drugs
Journal: Current Drug Targets - Infectious Disorders
Volume: 5 Issue: 1 Year: 2005 Page: 29-37
Author(s): L. M. Schang
Inhibiting Cyclin-Dependent Kinase / Cyclin Activity for the Treatment of Cancer and Cardiovascular Disease
Journal: Current Pharmaceutical Biotechnology
Volume: 4 Issue: 1 Year: 2003 Page: 21-37
Author(s):
Cyclin-Dependent Kinase Inhibitors as Anticancer Drugs
Journal: Current Drug Targets
Volume: 11 Issue: 3 Year: 2010 Page: 291-302
Author(s): Vladimir Krystof, Stjepan Uldrijan
Promotion of Apoptosis in Cancer Cells by Selective Purine-Derived Pharmacological CDK Inhibitors: One Outcome, Many Mechanisms
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 3 Year: 2011 Page: 256-271
Author(s): Jozefa Wasierska-Gadek, Margarita Maurer
Progress of CDK4/6 Inhibitor Palbociclib in the Treatment of Cancer
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18 Issue: 9 Year: 2018 Page: 1241-1251
Author(s): Fengquan Chen,Chunxi Liu,Jian Zhang,Wenfang Xu,Yingjie Zhang